About
Our Story
Honorary President
Big Issue
Team
Consultants
Business Segments
Investment
Strategy
Portfolio
Pharmaceutical
ESG
Overview
Sustainable Governance
Environment Mangement
Diversity, Equity & Inclusion
Social Relationships
Downloads
Investors
Overview
Financial Information
Shareholder’s Services
Corporate Governance
FAQ
News
Careers
Job Openings
Contact
繁體中文
Financial Information
Earnings Releases
No data available
5/34
Financial Reports
Year
select year
2025
2024
2023
2022
2021
2020
Title
Download
Consolidated Financial Statements and Independent Auditors’ Review Report for the Six Months Ended June 30, 2025 and 2024
Consolidated Financial Statements and Independent Auditors’ Review Report for the Three Months Ended March 31, 2025 and 2024
Operating Revenue